Regulation of S100A10 by the PML-RAR-α oncoprotein

Paul A. O'Connell, Patricia A. Madureira, Jason N. Berman, Robert S. Liwski, David M. Waisman

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

60 Citas (Scopus)

Resumen

Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia that results from the expression of the promyelocytic leukemia-retinoic acid receptor α (PML-RAR-α) oncoprotein. It is characterized by severe hemorrhagic complications due in part to excessive fibrinolysis, resulting from the excessive generation of the fibrinolytic enzyme, plasmin, at the cell surface of the PML cells. The treatment of patients with alltrans retinoic acid (ATRA) effectively ameliorates the disease by promoting the destruction of the PML-RAR-α oncoprotein. In the present study we show for the first time that the plasminogen receptor, S100A10, is present on the extracellular surface of APL cells and is rapidly downregulated in response to all-trans retinoic acid. The loss of S100A10 is concomitant with a loss in fibrinolytic activity. Furthermore, the induced expression of the PML-RAR-α oncoprotein increased the expression of cell surface S100A10 and also caused a dramatic increase in fibrinolytic activity. Depletion of S100A10 by RNA interference effectively blocked the enhanced fibrinolytic activity observed after induction of the PML-RAR-α oncoprotein. These experiments show that S100A10 plays a crucial role in the generation of plasmin leading to fibrinolysis, thus providing a link to the clinical hemorrhagic phenotype of APL.

Idioma originalEnglish
Páginas (desde-hasta)4095-4105
Número de páginas11
PublicaciónBlood
Volumen117
N.º15
DOI
EstadoPublished - abr. 14 2011

ASJC Scopus Subject Areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Huella

Profundice en los temas de investigación de 'Regulation of S100A10 by the PML-RAR-α oncoprotein'. En conjunto forman una huella única.

Citar esto